These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 3426357)

  • 1. [IgE concentration in the serum of patients with neurocysticercosis].
    Gorodezky C; Díaz ML; Escobar-Gutiérrez A; Flisser A
    Arch Invest Med (Mex); 1987; 18(3):225-7. PubMed ID: 3426357
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrospinal fluid IgE and the diagnosis of cerebral cysticercosis.
    Goldberg AS; Heiner DC; Firemark HM; Goldberg MA
    Bull Los Angeles Neurol Soc; 1981; 46():21-5. PubMed ID: 7052908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human neurocysticercosis. IgE in cerebrospinal fluid.
    De Melo CS; Vaz AJ; Nakamura PM; Da Silva MV; Machado Ade B
    Arq Neuropsiquiatr; 1997 Mar; 55(1):8-11. PubMed ID: 9332554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of humoral immune components in human cysticercosis.
    Correa D; Dalma D; Espinoza B; Plancarte A; Rabiela MT; Madrazo I; Gorodezky C; Flisser A
    J Parasitol; 1985 Oct; 71(5):535-41. PubMed ID: 3903094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoglobulins in the cerebrospinal fluid and their clinical-diagnostic significance].
    Delank HW
    Nervenarzt; 1971 Sep; 42(9):483-90. PubMed ID: 5092939
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurocysticercosis.
    Barry M; Kaldjian LC
    Semin Neurol; 1993 Jun; 13(2):131-43. PubMed ID: 8356346
    [No Abstract]   [Full Text] [Related]  

  • 7. Cysticercosis of cerebellopontine cistern: differential diagnosis using MRI.
    Chang JH; Chang JW; Park YG; Kim TS
    Acta Neurochir (Wien); 2004 Apr; 146(4):325-8. PubMed ID: 15057525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral and cellular immune response within the subarachnoid space of patients with neurocysticercosis.
    Ostrosky-Zeichner L; García-Mendoza E; Ríos C; Sotelo J
    Arch Med Res; 1996; 27(4):513-7. PubMed ID: 8987187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of immunodiagnosis by ELISA and Western blotting for the diagnostic and therapeutic management of neurocysticercosis].
    Simac C; Michel P; Andriantsimahavandy A; Esterre P; Michault A
    Arch Inst Pasteur Madagascar; 1994; 61(1):21-7. PubMed ID: 7778946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of concentrated CSF hemagglutination technique for the diagnosis of cerebral cysticercosis.
    Martínez-Cairo S; Ruíz-Macias C; López-Román M; Mateos-Gómez H
    Arch Invest Med (Mex); 1980; 11(3):347-59. PubMed ID: 7469655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidemiology of cysticercosis in Madagascar].
    Michel P; Callies P; Raharison H; Guyon P; Holvoet L; Genin C
    Bull Soc Pathol Exot; 1993; 86(1):62-7. PubMed ID: 8504266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the ELISA method for diagnosis of human cysticercosis in an endemic region].
    Agudelo P; Botero D; Palacio LG
    Biomedica; 2005 Dec; 25(4):488-95. PubMed ID: 16433175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of serum from neurocysticercosis patients on the structure and viability of Taenia solium oncospheres.
    Molinari JL; Tato P; Lara-Aguilera R; White AC
    J Parasitol; 1993 Feb; 79(1):124-7. PubMed ID: 8437052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocysticercosis: parasitology, clinical presentation, diagnosis, and recent advances in management.
    Cook GC
    Q J Med; 1988 Aug; 68(256):575-83. PubMed ID: 3076674
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of ELISA and counterimmunoelectrophoresis in diagnosis of human neurocysticercosis in Chile].
    Retamal C; Zulantay I; Sariego H; Melo R; Apt W
    Rev Med Chil; 1995 Dec; 123(12):1461-6. PubMed ID: 8733262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of human neurocysticercosis by ELISA-IgG using a purified antigen].
    Salinas P; Sandoval L; Rugiero E; Contreras MC
    Bol Chil Parasitol; 1996; 51(3-4):85-90. PubMed ID: 9302781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of praziquantel in neurocysticercosis.
    Spina-França A; Nobrega JP; Livramento JA; Machado LR
    Tropenmed Parasitol; 1982 Mar; 33(1):1-4. PubMed ID: 7101435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases.
    Sotelo J; Guerrero V; Rubio F
    Arch Intern Med; 1985 Mar; 145(3):442-5. PubMed ID: 3977513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of lymphocyte E rosette formation in cerebrospinal fluid and peripheral blood.
    Zhang YH; Yuan JM
    Chin Med J (Engl); 1980 Nov; 93(11):789-94. PubMed ID: 6775891
    [No Abstract]   [Full Text] [Related]  

  • 20. Is the course of neurocysticercosis modified by treatment with anthelmintic agents?
    Del Brutto OH
    Arch Intern Med; 1997 Jan; 157(1):128-30. PubMed ID: 8996050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.